Novacyt: Monthly Review of the Liquidity and Voting Rights Agreement

Novacyt, an international specialist in clinical diagnostics, has published its monthly results for August 2024 concerning the liquidity contract entrusted to Invest Securities SA. During this month, 99,268 shares were purchased at a price ranging from €0.52 to €1.35, while 131,896 shares were sold at prices ranging from €0.53 to €1.36.

As of the close of trading on August 31, 2024, the Company held 20,436 ordinary shares in treasury. The total number of ordinary shares is 70,626,248, a figure that may serve as a reference for shareholders wishing to declare or modify their interest in the Company.

Novacyt, a subscriber to the liquidity agreement since 2016, received shareholder approval in July 2024 for share purchases of up to €5.00 per share, for a maximum amount of €200,000. The agreement stipulates that Invest Securities acts independently, and it is remunerated €10,000 per year for its services. This agreement is governed by French law.